ScholarIQanswers from OpenAlex
Otsuka Pharmaceutical
FunderResearch funding and supported work
Otsuka Pharmaceutical is a funder indexed in ScholarIQ from OpenAlex.
What is known about Otsuka Pharmaceutical?
ScholarIQrecord summary
company
How many works does Otsuka Pharmaceutical have?
ScholarIQindexed works
Otsuka Pharmaceutical has 4,944 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Otsuka Pharmaceutical?
ScholarIQopenalex
The OpenAlex for Otsuka Pharmaceutical is on the source record.
What is the ROR of Otsuka Pharmaceutical?
ScholarIQror
The ROR for Otsuka Pharmaceutical is on the source record.
What are the most-cited papers on Otsuka Pharmaceutical?
ScholarIQmost cited works
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
Gerasimos Filippatos, Stefan D. Anker, Michael Böhm, Mihai Gheorghiade, Lars Køber, Henry Krum, Aldo P. Maggioni, Piotr Ponikowski, Adriaan A. Voors, Faı̈ez Zannad, So Young Kim, Christina Nowack, Giovanni Palombo, Peter Kolkhof, Nina Kimmeskamp‐Kirschbaum, Alexander Pieper, Bertram Pitt
KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary
Vicente E. Torres, Curie Ahn, Thijs R.M. Barten, Godela Brosnahan, Melissa A. Cadnapaphornchai, Arlene B. Chapman, Émilie Cornec-Le Gall, Joost P.H. Drenth, Ron T. Gansevoort, Peter C. Harris, Tess Harris, Shigeo Horie, Max C. Liebau, Michele Liew, Andrew Mallett, Changlin Mei, Djalila Mekahli, Dwight Odland, Albert Ong, Luiz F. Onuchic, York Pei, Ronald D. Perrone, Gopala K. Rangan, Brian Rayner, Roser Torrá, Ethan M. Balk, Craig E. Gordon, Amy Earley, Reem A. Mustafa, Olivier Devuyst
Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review
Krzysztof Kiryluk, Daniel E. Freedberg, Jai Radhakrishnan, Leslie Segall, Judith S. Jacobson, Mohit Mathur, Sumit Mohan, Alfred I. Neugut
The societal economic burden of autosomal dominant polycystic kidney disease in the United States
Martin Cloutier, Ameur M. Manceur, Annie Guérin, Myrlene Sanon Aigbogun, Dorothee Oberdhan, Marjolaine Gauthier‐Loiselle
Double-Blind, Randomized, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Eplerenone in Japanese Patients With Chronic Heart Failure (J-EMPHASIS-HF)
Hiroyuki Tsutsui, Hiroshi Ito, Masafumi Kitakaze, Issei Komuro, Toyoaki Murohara, Tohru Izumi, Kenji Sunagawa, Yoshio Yasumura, Masafumi Yano, K. Yamamoto, Tsutomu Yoshikawa, Takayoshi Tsutamoto, Junwei Zhang, Akifumi Okayama, Yoshihiko Ichikawa, Kazuhiro Kanmuri, Masunori Matsuzaki, for the J-EMPHASIS-HF Study Group